Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4979

Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response

Analysis of lapatinib-resistant ErbB2-positive cells treated with 0.1 or 1 uM lapatinib. Lapatinib is an EGFR/ErbB2 inhibitor used to treat ErbB2‐positive advanced or metastatic breast cancer. Results provide insight into the mechanisms underlying the development of resistance to lapatinib.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 cell type, 3 dose sets

Platform:: GPL6947
Series:: GSE38376
18 Samples

DataSet

Accession:: GDS4979

ID:: 4979

Analyze DataSet

Supplemental Content

Important Links

Recent activity

Clear Turn Off Turn On

Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Accession: GDS4979

GEO DataSets
Related DataSets for GEO Profiles (Select 108799376) (1)
GEO DataSets
Escherichia coli strain Past_Har_7 contig_1, whole genome shotgun sequence
Escherichia coli strain Past_Har_7 contig_1, whole genome shotgun sequence
gi|2776437561|ref|NZ_JBFOAN01000000 gnl|WGS:NZ_JBFOAN01|contig_1

Nucleotide
OMIM for MedGen (Select 900688) (1)
OMIM
Escherichia coli strain YF-1 chromosome, complete genome
Escherichia coli strain YF-1 chromosome, complete genome
gi|2776433175|ref|NZ_CP161809.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets